Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, October 9, 2018
[ Tue, Oct 09th 2018
] - WOPRAI
[ Tue, Oct 09th 2018
] - WOPRAI
[ Tue, Oct 09th 2018
] - WOPRAI
[ Tue, Oct 09th 2018
] - WOPRAI
[ Tue, Oct 09th 2018
] - WOPRAI
[ Tue, Oct 09th 2018
] - WOPRAI
[ Tue, Oct 09th 2018
] - WOPRAI
[ Tue, Oct 09th 2018
] - WOPRAI
Mon, October 8, 2018
[ Mon, Oct 08th 2018
] - WOPRAI
[ Mon, Oct 08th 2018
] - WOPRAI
[ Mon, Oct 08th 2018
] - WOPRAI
[ Mon, Oct 08th 2018
] - WOPRAI
[ Mon, Oct 08th 2018
] - WOPRAI
[ Mon, Oct 08th 2018
] - WOPRAI
[ Mon, Oct 08th 2018
] - WOPRAI
[ Mon, Oct 08th 2018
] - WOPRAI
[ Mon, Oct 08th 2018
] - WOPRAI
[ Mon, Oct 08th 2018
] - WOPRAI
[ Mon, Oct 08th 2018
] - WOPRAI
[ Mon, Oct 08th 2018
] - WOPRAI
[ Mon, Oct 08th 2018
] - WOPRAI
[ Mon, Oct 08th 2018
] - WOPRAI
[ Mon, Oct 08th 2018
] - WOPRAI
[ Mon, Oct 08th 2018
] - WOPRAI
[ Mon, Oct 08th 2018
] - WOPRAI
[ Mon, Oct 08th 2018
] - WOPRAI
David Nierengarten Maintained (BOLD) at Buy with Increased Target to $52 on, Oct 8th, 2018
David Nierengarten of Wedbush, Maintained "Boundless Bio, Inc." (BOLD) at Buy with Increased Target from $49 to $52 on, Oct 8th, 2018.
David has made no other calls on BOLD in the last 4 months.
There are 2 other peers that have a rating on BOLD. Out of the 2 peers that are also analyzing BOLD, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Mohit Bansal of "Citigroup" Initiated at Hold and Held Target at $40 on, Tuesday, August 21st, 2018
This is the rating of the analyst that currently disagrees with David
- Difei Yang of "Mizuho" Upgraded from Hold to Strong Buy on, Wednesday, August 8th, 2018
Similar Stocks and Investing Articles
[ Tue, Sep 11th 2018
] - WOPRAI
[ Fri, Aug 10th 2018
] - WOPRAI
[ Fri, Feb 09th 2018
] - WOPRAI
[ Mon, Sep 21st 2015
] - WOPRAI
[ Fri, Oct 17th 2014
] - WOPRAI
[ Tue, Oct 14th 2014
] - WOPRAI
[ Tue, Oct 14th 2014
] - WOPRAI
[ Mon, Dec 03rd 2012
] - WOPRAI
[ Wed, Oct 03rd 2012
] - WOPRAI
[ Thu, Sep 06th 2012
] - WOPRAI